Skip to main content
Back to News
Edison Scientific raised 70 million dollars at a 250 million dollar valuation to scale its autonomou...
Funding
1 min read
US

Edison Scientific raised 70 million dollars at a 250 million dollar valuation to scale its autonomou...

The AMW Read

Updates the Vertical AI - Healthcare/Bio segment with a player demonstrating the transition of AI agents from information retrieval to autonomous scientific discovery (agentic workflows) in drug discovery.
NoveltySignificance
Healthcare & Bio Β· Player MapAI Agents Β· Definition
Edison Scientific
Edison Scientific

AI in Biotech / Drug Discovery

View Company Profile

Edison Scientific raised 70 million dollars at a 250 million dollar valuation to scale its autonomous researcher, Kosmos. πŸ§ͺ The system processes 1,500 papers and 42,000 lines of code per run, turning six months of labor into a 12-hour task. With a 79 percent reproducibility rate, it has already identified novel genetic targets for heart failure. This marks a structural pivot where AI agents transition from simple information retrieval to verifiable, high-speed scientific discovery. πŸš€

#AI #Biotech #EdisonScientific #Innovation

How This Connects

Based on Healthcare & Bio Β· Player Map

  1. 1w agoAdaptyv raises €34.35M Series A for automated protein-design labAdaptyv
  2. 2w agoSkyLabs Sets September KOSDAQ Listing, Discloses $18.4M H1 2026 Revenue and Otsuka Distribution DealSkyLabs
  3. 2w agoVivodyne, a biotech startup spun out of the University of Pennsylvania in 2021, has unveiled HIVE, a...Vivodyne
  4. 8mo agoEdison Scientific raised 70 million dollars at a 250 million dollar valuation to scale its autonomou... Β· THIS ARTICLE

More news from Edison Scientific

Stay updated with the latest news and announcements from Edison Scientific.

View all Edison Scientific news

Discover AI Startups

Explore 5,000+ AI companies with VC-grade analysis, funding data, and investment insights.

Explore Dashboard